Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non-Small-Cell Lung Cancer

Matthew S. Lara, William S. Holland, Danielle Chinn, Rebekah A. Burich, Primo N. Lara, David R. Gandara, Karen Kelly, Philip C. Mack

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non-Small-Cell Lung Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences